Sheep Colostrum Powder (Ovis aries)

Sheep colostrum powder (Ovis aries) is the first milk produced by ewes after lambing, concentrated into powder form and rich in bioactive peptides including ACE-inhibitory caseins, antimicrobial β-casein fragments, and antioxidant κ-casein sequences. These peptides exert measurable effects on blood pressure regulation, pathogen defense, and oxidative stress modulation through enzyme inhibition and membrane disruption mechanisms.

Origin & History

Sheep colostrum powder is derived from the first milk secreted by ewes (Ovis aries) within 24-48 hours after lambing, containing approximately 26.76% total solids with high concentrations of proteins (13.94%), fats (9.94%), and bioactive compounds. The colostrum is processed into powder form through standardized drying and concentration methods to preserve its nutrient density and bioactive peptides.

Historical & Cultural Context

The provided research does not contain information regarding traditional medicine use of sheep colostrum across different medical systems or historical applications. Traditional use documentation is absent from the available sources.

Health Benefits

• Contains ACE-inhibitory peptides (α-casein and κ-casein) with IC50 values of 2.4-28.9 μM - in vitro evidence only
• Provides antimicrobial peptides (β-casein VMFPPQ) active against gram-negative bacteria - laboratory studies only
• Delivers antioxidant κ-casein peptides (HPHPHLSF) that inhibit linoleic acid oxidation - biochemical assays only
• Contains lactoferrin (692 amino acids) that enhances phagocytic activity and immune response - mechanism studies only
• Supplies high-quality proteins including β-lactoglobulin with methionine content - compositional analysis only

How It Works

ACE-inhibitory peptides derived from α-casein and κ-casein fractions competitively inhibit angiotensin-converting enzyme with IC50 values ranging from 2.4 to 28.9 μM, reducing the conversion of angiotensin I to the vasoconstrictive angiotensin II. The antimicrobial peptide VMFPPQ, derived from β-casein, disrupts gram-negative bacterial outer membranes through electrostatic interaction and lipopolysaccharide binding, compromising membrane integrity. Antioxidant κ-casein peptides including the sequence HPHPHLSF scavenge reactive oxygen species and inhibit lipid peroxidation by chelating pro-oxidant metal ions and donating hydrogen atoms to free radical chains.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses evaluating sheep colostrum powder were found in the provided research. The available evidence consists entirely of biochemical composition studies and in vitro bioactivity assays documenting the presence of bioactive compounds rather than clinical efficacy in human populations.

Clinical Summary

The majority of evidence supporting sheep colostrum powder's bioactive properties comes from in vitro and laboratory studies, with no large-scale randomized controlled trials specifically isolating Ovis aries colostrum in human subjects. ACE-inhibitory activity with IC50 values of 2.4–28.9 μM has been confirmed in cell-free enzymatic assays, and antimicrobial efficacy of VMFPPQ has been demonstrated against gram-negative strains in bacterial culture models. Broader bovine colostrum human trials (n=20–100 range studies) suggest immunoglobulin and growth factor transfer, but direct extrapolation to sheep-specific colostrum powder in humans remains speculative. The current evidence base supports biological plausibility but cannot confirm clinical endpoints such as blood pressure reduction or infection prevention in human populations.

Nutritional Profile

Sheep colostrum powder is a nutrient-dense protein source with a distinct compositional advantage over bovine colostrum in several bioactive fractions. **Macronutrients (per 100 g powder, typical spray-dried):** Protein 45–65 g (predominantly casein ~80% and whey ~20%), Fat 18–28 g (rich in medium-chain fatty acids C6:0–C12:0 comprising ~15–18% of total fat, conjugated linoleic acid (CLA) ~0.8–1.2 g), Carbohydrates 12–20 g (primarily lactose), Ash 5–8 g. Caloric density approximately 420–500 kcal/100 g. **Protein fractions:** Immunoglobulins (IgG 30–80 mg/g, IgA 2–5 mg/g, IgM 3–8 mg/g — notably higher total Ig concentration than bovine colostrum by ~1.5–2×), Lactoferrin 1.5–4.5 mg/g (692 amino acid glycoprotein, iron-binding capacity ~30% saturation), α-Lactalbumin 2–4 mg/g, β-Lactoglobulin 5–12 mg/g, Serum albumin 1–2 mg/g. Casein sub-fractions include αs1-casein, αs2-casein, β-casein, and κ-casein which serve as precursor sequences for bioactive peptides including ACE-inhibitory (IC50 2.4–28.9 μM), antimicrobial (VMFPPQ from β-casein), and antioxidant (HPHPHLSF from κ-casein) peptides. **Growth factors:** IGF-1 50–150 ng/g, IGF-2 10–30 ng/g, TGF-β1 15–50 ng/g, TGF-β2 100–400 ng/g, EGF 5–15 ng/g — concentrations generally 2–5× higher than mature milk. **Minerals:** Calcium 800–1200 mg/100 g (partially bound to casein micelles enhancing bioavailability ~35–40%), Phosphorus 600–900 mg/100 g, Magnesium 80–120 mg/100 g, Zinc 5–12 mg/100 g (bound to casein and lactoferrin improving absorption), Iron 0.5–1.5 mg/100 g (lactoferrin-bound fraction shows enhanced bioavailability), Selenium 15–30 μg/100 g, Sodium 400–600 mg/100 g, Potassium 700–1100 mg/100 g. **Vitamins:** Vitamin A (retinol) 300–900 μg/100 g (colostrum contains 3–5× higher retinol than mature sheep milk), Vitamin E (α-tocopherol) 2–5 mg/100 g, Vitamin D3 0.3–1.0 μg/100 g, Vitamin B12 1.5–4.0 μg/100 g, Riboflavin (B2) 0.8–1.5 mg/100 g, Niacin (B3) 0.5–1.0 mg/100 g, Pantothenic acid (B5) 2–4 mg/100 g, Folate 5–15 μg/100 g, Vitamin C 2–8 mg/100 g (heat-labile, reduced by spray-drying). **Additional bioactive compounds:** Oligosaccharides 0.5–1.5 g/100 g (sialylated oligosaccharides including 3'-sialyllactose and 6'-sialyllactose as predominant species, serving as prebiotic substrates), Gangliosides 10–20 mg/100 g, Phospholipids (sphingomyelin, phosphatidylcholine, phosphatidylethanolamine) 1–3 g/100 g within the milk fat globule membrane (MFGM) fraction, Lysozyme 0.1–0.5 mg/g, Lactoperoxidase 10–30 μg/g. **Bioavailability notes:** Sheep milk proteins exhibit smaller casein micelle size (~180 nm vs ~200 nm bovine) potentially improving digestibility and peptide release kinetics. The A2-type β-casein predominance in sheep milk (vs A1 in many bovine breeds) may reduce BCM-7 release during digestion. Fat-soluble vitamin bioavailability is enhanced by the naturally homogenized smaller fat globules (~3.3 μm). Mineral bioavailability benefits from caseinophosphopeptide (CPP) formation during digestion, which solubilizes calcium and zinc in the intestinal lumen. Immunoglobulin survival through gastric transit in adults is estimated at 10–25% without enteric protection.

Preparation & Dosage

No clinically studied dosage ranges for sheep colostrum powder in humans are available from the research provided. Without human clinical trial data, evidence-based dosage recommendations cannot be established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Bovine colostrum, lactoferrin, probiotics, vitamin D, zinc

Safety & Interactions

Sheep colostrum powder is generally considered safe for healthy adults when used as directed, but individuals with dairy or milk protein allergies should avoid it due to cross-reactive casein and whey proteins. Those taking ACE inhibitor medications such as lisinopril or enalapril should exercise caution, as additive blood pressure-lowering effects from ACE-inhibitory peptides are theoretically possible, though clinically unconfirmed. Pregnant and breastfeeding women should consult a healthcare provider before use, as no dedicated safety studies exist for this population. Individuals with lactose intolerance may experience gastrointestinal discomfort, and immunocompromised individuals should note that colostrum-derived immunoglobulins may interact unpredictably with immune-modulating therapies.